Lyophilised protein formulations as a patient-centric dosage form: A contribution toward sustainability paradigm

At present, society has embraced the fact apropos population aging and climate changes, that demand, amongst others, innovative pharmaceutical technologies, emphasising the development of patient-specific delivery systems and thus the provision of efficient and sustainable drugs. Protein drugs for s...

Full description

Saved in:
Bibliographic Details
Main Authors: Žiberna Maja Bjelošević, Grabnar Pegi Ahlin, Gašperlin Mirjana, Matjaž Mirjam Gosenca
Format: Article
Language:English
Published: Sciendo 2024-06-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.2478/acph-2024-0013
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832569085432430592
author Žiberna Maja Bjelošević
Grabnar Pegi Ahlin
Gašperlin Mirjana
Matjaž Mirjam Gosenca
author_facet Žiberna Maja Bjelošević
Grabnar Pegi Ahlin
Gašperlin Mirjana
Matjaž Mirjam Gosenca
author_sort Žiberna Maja Bjelošević
collection DOAJ
description At present, society has embraced the fact apropos population aging and climate changes, that demand, amongst others, innovative pharmaceutical technologies, emphasising the development of patient-specific delivery systems and thus the provision of efficient and sustainable drugs. Protein drugs for subcutaneous administration, by allowing less frequent application, represent one of the most important parts of the pharmaceutical field, but their development is inevitably faced with obstacles in providing protein stability and suitable formulation viscosity. To gain further knowledge and fill the gaps in the already constructed data platform for the development of monoclonal antibody formulations, we designed a study that examines small model proteins, i.e., bovine serum albumin. The main aim of the presented work is to evaluate the effect of protein concentrations on critical quality attributes of both, pre-lyophilised liquid formulations, and lyophilised products. Through the study, the hypothesis that increasing protein concentration leads to higher viscosity and higher reconstitution time without affecting the stability of the protein was confirmed. The most important finding is that sucrose plays a key role in the lyophilisation of investigated protein, nevertheless, it can be predicted that, to ensure the beneficial effect of mannitol, its amount has to prevail over the amount of sucrose.
format Article
id doaj-art-e595301f88ab4b61a7d0b00bd497a93a
institution Kabale University
issn 1846-9558
language English
publishDate 2024-06-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-e595301f88ab4b61a7d0b00bd497a93a2025-02-02T23:21:01ZengSciendoActa Pharmaceutica1846-95582024-06-0174228930010.2478/acph-2024-0013Lyophilised protein formulations as a patient-centric dosage form: A contribution toward sustainability paradigmŽiberna Maja Bjelošević0Grabnar Pegi Ahlin1Gašperlin Mirjana2Matjaž Mirjam Gosenca31University of Ljubljana, Faculty of Pharmacy, Department of Pharmaceutical Technology, 1000Ljubljana, Slovenia1University of Ljubljana, Faculty of Pharmacy, Department of Pharmaceutical Technology, 1000Ljubljana, Slovenia1University of Ljubljana, Faculty of Pharmacy, Department of Pharmaceutical Technology, 1000Ljubljana, Slovenia1University of Ljubljana, Faculty of Pharmacy, Department of Pharmaceutical Technology, 1000Ljubljana, SloveniaAt present, society has embraced the fact apropos population aging and climate changes, that demand, amongst others, innovative pharmaceutical technologies, emphasising the development of patient-specific delivery systems and thus the provision of efficient and sustainable drugs. Protein drugs for subcutaneous administration, by allowing less frequent application, represent one of the most important parts of the pharmaceutical field, but their development is inevitably faced with obstacles in providing protein stability and suitable formulation viscosity. To gain further knowledge and fill the gaps in the already constructed data platform for the development of monoclonal antibody formulations, we designed a study that examines small model proteins, i.e., bovine serum albumin. The main aim of the presented work is to evaluate the effect of protein concentrations on critical quality attributes of both, pre-lyophilised liquid formulations, and lyophilised products. Through the study, the hypothesis that increasing protein concentration leads to higher viscosity and higher reconstitution time without affecting the stability of the protein was confirmed. The most important finding is that sucrose plays a key role in the lyophilisation of investigated protein, nevertheless, it can be predicted that, to ensure the beneficial effect of mannitol, its amount has to prevail over the amount of sucrose.https://doi.org/10.2478/acph-2024-0013subcutaneous administrationbovine serum albuminlyophilisationviscosityreconstitution timestability
spellingShingle Žiberna Maja Bjelošević
Grabnar Pegi Ahlin
Gašperlin Mirjana
Matjaž Mirjam Gosenca
Lyophilised protein formulations as a patient-centric dosage form: A contribution toward sustainability paradigm
Acta Pharmaceutica
subcutaneous administration
bovine serum albumin
lyophilisation
viscosity
reconstitution time
stability
title Lyophilised protein formulations as a patient-centric dosage form: A contribution toward sustainability paradigm
title_full Lyophilised protein formulations as a patient-centric dosage form: A contribution toward sustainability paradigm
title_fullStr Lyophilised protein formulations as a patient-centric dosage form: A contribution toward sustainability paradigm
title_full_unstemmed Lyophilised protein formulations as a patient-centric dosage form: A contribution toward sustainability paradigm
title_short Lyophilised protein formulations as a patient-centric dosage form: A contribution toward sustainability paradigm
title_sort lyophilised protein formulations as a patient centric dosage form a contribution toward sustainability paradigm
topic subcutaneous administration
bovine serum albumin
lyophilisation
viscosity
reconstitution time
stability
url https://doi.org/10.2478/acph-2024-0013
work_keys_str_mv AT zibernamajabjelosevic lyophilisedproteinformulationsasapatientcentricdosageformacontributiontowardsustainabilityparadigm
AT grabnarpegiahlin lyophilisedproteinformulationsasapatientcentricdosageformacontributiontowardsustainabilityparadigm
AT gasperlinmirjana lyophilisedproteinformulationsasapatientcentricdosageformacontributiontowardsustainabilityparadigm
AT matjazmirjamgosenca lyophilisedproteinformulationsasapatientcentricdosageformacontributiontowardsustainabilityparadigm